X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
58
PharmaCompass offers a list of Mefenamic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mefenamic Acid manufacturer or Mefenamic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mefenamic Acid manufacturer or Mefenamic Acid supplier.
PharmaCompass also assists you with knowing the Mefenamic Acid API Price utilized in the formulation of products. Mefenamic Acid API Price is not always fixed or binding as the Mefenamic Acid Price is obtained through a variety of data sources. The Mefenamic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ponstan Forte manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ponstan Forte, including repackagers and relabelers. The FDA regulates Ponstan Forte manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ponstan Forte API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ponstan Forte manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ponstan Forte supplier is an individual or a company that provides Ponstan Forte active pharmaceutical ingredient (API) or Ponstan Forte finished formulations upon request. The Ponstan Forte suppliers may include Ponstan Forte API manufacturers, exporters, distributors and traders.
click here to find a list of Ponstan Forte suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ponstan Forte DMF (Drug Master File) is a document detailing the whole manufacturing process of Ponstan Forte active pharmaceutical ingredient (API) in detail. Different forms of Ponstan Forte DMFs exist exist since differing nations have different regulations, such as Ponstan Forte USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ponstan Forte DMF submitted to regulatory agencies in the US is known as a USDMF. Ponstan Forte USDMF includes data on Ponstan Forte's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ponstan Forte USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ponstan Forte suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ponstan Forte Drug Master File in Japan (Ponstan Forte JDMF) empowers Ponstan Forte API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ponstan Forte JDMF during the approval evaluation for pharmaceutical products. At the time of Ponstan Forte JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ponstan Forte suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ponstan Forte Drug Master File in Korea (Ponstan Forte KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ponstan Forte. The MFDS reviews the Ponstan Forte KDMF as part of the drug registration process and uses the information provided in the Ponstan Forte KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ponstan Forte KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ponstan Forte API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ponstan Forte suppliers with KDMF on PharmaCompass.
A Ponstan Forte CEP of the European Pharmacopoeia monograph is often referred to as a Ponstan Forte Certificate of Suitability (COS). The purpose of a Ponstan Forte CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ponstan Forte EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ponstan Forte to their clients by showing that a Ponstan Forte CEP has been issued for it. The manufacturer submits a Ponstan Forte CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ponstan Forte CEP holder for the record. Additionally, the data presented in the Ponstan Forte CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ponstan Forte DMF.
A Ponstan Forte CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ponstan Forte CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ponstan Forte suppliers with CEP (COS) on PharmaCompass.
A Ponstan Forte written confirmation (Ponstan Forte WC) is an official document issued by a regulatory agency to a Ponstan Forte manufacturer, verifying that the manufacturing facility of a Ponstan Forte active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ponstan Forte APIs or Ponstan Forte finished pharmaceutical products to another nation, regulatory agencies frequently require a Ponstan Forte WC (written confirmation) as part of the regulatory process.
click here to find a list of Ponstan Forte suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ponstan Forte as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ponstan Forte API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ponstan Forte as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ponstan Forte and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ponstan Forte NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ponstan Forte suppliers with NDC on PharmaCompass.
Ponstan Forte Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ponstan Forte GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ponstan Forte GMP manufacturer or Ponstan Forte GMP API supplier for your needs.
A Ponstan Forte CoA (Certificate of Analysis) is a formal document that attests to Ponstan Forte's compliance with Ponstan Forte specifications and serves as a tool for batch-level quality control.
Ponstan Forte CoA mostly includes findings from lab analyses of a specific batch. For each Ponstan Forte CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ponstan Forte may be tested according to a variety of international standards, such as European Pharmacopoeia (Ponstan Forte EP), Ponstan Forte JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ponstan Forte USP).
Market Place
